Related Experiment Video
Updated: Jun 13, 2026
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Decrease in {beta}-cell proliferation precedes apoptosis during diabetes development in bio-breeding/worcester rat:
Gonzalo Pérez-Arana1, Manuel Blandino-Rosano, Arturo Prada-Oliveira
1Investigation Unit and Endocrinology and Nutrition Service, Puerta del Mar Hospital, 11009 Cádiz, Spain.
Endocrinology
|April 23, 2010
Summary
Early intervention targeting insulitis is crucial for preventing autoimmune diabetes. Exendin-4 and anti-interferon-gamma antibody restored beta-cell proliferation in preclinical models, suggesting new therapeutic avenues.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Autoimmune type 1 diabetes involves proinflammatory cytokine-mediated beta-cell apoptosis, leading to reduced beta-cell mass.
- The Bio-Breeding (BB) rat model exhibits beta-cell apoptosis starting around 9 weeks of age, following an earlier insulitis phase.
- Proinflammatory cytokines exert an antiproliferative effect on beta-cells, partially reversible by Exendin-4.
Purpose of the Study:
- To investigate changes in beta-cell apoptosis and proliferation during the insulitis stage in BB and Wistar rats.
- To evaluate the therapeutic potential of Exendin-4 and anti-interferon-gamma antibody in preventing autoimmune diabetes progression.
Main Methods:
- Analysis of pancreatic tissue sections from normal and thymectomized BB rats, and Wistar rats at various ages (5, 7, 9, 11 weeks).
- Assessment of beta-cell proliferation and apoptosis during the insulitis stage.
- Treatment with Exendin-4 in combination with anti-interferon-gamma antibody.
Main Results:
- BB rats showed decreased beta-cell proliferation and mass from 5 weeks of age, preceding apoptosis.
- Stable beta-cell proliferation was observed in Wistar and thymectomized BB rats.
- Combined treatment with Exendin-4 and anti-interferon-gamma antibody led to significant recovery of beta-cell proliferation during early insulitis.
Conclusions:
- Beta-cell proliferation reduction precedes apoptosis in autoimmune diabetes development.
- Early therapeutic intervention during the insulitis stage is critical.
- Exendin-4 and anti-interferon-gamma antibody show promise for novel therapeutic strategies targeting autoimmune diabetes by promoting beta-cell regeneration and inhibiting apoptosis.
More Related Videos
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...